Sökning: onr:"swepub:oai:DiVA.org:uu-418944" >
In patients with st...
-
White, Harvey D.Univ Auckland, Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand.
(författare)
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events
- Artikel/kapitelEngelska2020
Förlag, utgivningsår, omfång ...
-
Elsevier BV,2020
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-418944
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-418944URI
-
https://doi.org/10.1016/j.ahj.2020.04.004DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
BackgroundIn patients with stable coronary heart disease, it is not known whether achievement of standard of care (SOC) targets in addition to evidence-based medicine (EBM) is associated with lower major adverse cardiovascular events (MACE): cardiovascular death, myocardial infarction, and stroke.MethodsEBM use was recommended in the STabilisation of Atherosclerotic plaque By Initiation of darapLadIb TherapY trial. SOC targets were blood pressure (BP) <140/90 mm Hg and low-density lipoprotein-cholesterol (LDL-C) <100 mg/dL and <70 mg/dL. In patients with diabetes, glycosylated hemoglobin A1c (HbA1c) < 7% and BP of <130/80 mm Hg were recommended. Feedback to investigators about rates of EBM and SOC was provided regularly.ResultsIn 13,623 patients, 1-year landmark analysis assessed the association between EBM, SOC targets, and MACE during follow-up of 2.7 years (median) after adjustment in a Cox proportional hazards model.At 1 year, aspirin was prescribed in 92.5% of patients, statins in 97.2%, β-blockers in 79.0%, and angiotensin-converting enzyme inhibitors/angiotensin-II receptor blockers in 76.9%. MACE was lower with LDL-C < 100 mg/dL (70-99 mg/dL) compared with LDL-C ≥ 100 mg/dL (hazard ratio [HR] 0.694, 95% CI 0.594-0.811) and lower with LDL-C < 70 mg/dL compared with LDL-C < 100 mg/dL (70-99 mg/dL) (HR 0.834, 95% CI 0.708-0.983). MACE was lower with HbA1c < 7% compared with HbA1c ≥ 7% (HR 0.705, 95% CI 0.573-0.866). There was no effect of BP targets on MACE.ConclusionsMACE was lower with LDL-C < 100 mg/dL (70-99 mg/dL) and even lower with LDL-C < 70 mg/dL. MACE in patients with diabetes was lower with HbA1c < 7%. Achievement of targets is associated with improved patient outcomes.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Stewart, Ralph A. H.Univ Auckland, Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand.
(författare)
-
Dolby, Anthony J.Milpk Hosp, Johannesburg, South Africa.
(författare)
-
Stebbins, AmandaDuke Clin Res Inst, Duke Med, Durham, NC USA.
(författare)
-
Cannon, Christopher P.Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.;Harvard Med Sch, Harvard Clin Res Inst, Boston, MA 02115 USA.
(författare)
-
Budaj, AndrzejGrochowski Hosp, Postgrad Med Sch, Warsaw, Poland.
(författare)
-
Linhart, AlesGen Univ Hosp, Dept Med 2, Dept Cardiovasc Med, Prague, Czech Republic.
(författare)
-
Pais, PremSt Johns Res Inst, Bangalore, Karnataka, India.
(författare)
-
Diaz, RafaelInst Cardiovasc Rosario, Estudios Cordiol Latinoamer, Rosario, Argentina.
(författare)
-
Steg, Philippe GabrielHop Bichat Claude Bernard, AP HP, Paris, France.;Paris Univ, FACT French Alliance Cardiovasc Trials, INSERM, Paris, France.;Imperial Coll, Natl Heart & Lung Inst, Royal Brampton Hosp, London, England.
(författare)
-
Krug-Gourley, SueGlaxoSmithKline, Metab Pathways & Cardiovasc Therapeut Area, King Of Prussia, PA USA.
(författare)
-
Granger, Christopher B.Duke Clin Res Inst, Duke Med, Durham, NC USA.
(författare)
-
Hochman, Judith S.NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.
(författare)
-
Koenig, WolfgangUniv Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany.;Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany.;German Ctr Cardiovasc Res, Heart Alliance, Partner Site Munich, Munich, Germany.
(författare)
-
Harrington, Robert A.Stanford Univ, Stanford Ctr Clin Res, Dept Med, Stanford, CA 94305 USA.
(författare)
-
Held, Claes,1956-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi(Swepub:uu)clahe947
(författare)
-
Wallentin, Lars,1943-Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)larswall
(författare)
-
Univ Auckland, Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand.Milpk Hosp, Johannesburg, South Africa.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:American Heart Journal: Elsevier BV225, s. 97-1070002-87031097-6744
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
White, Harvey D.
-
Stewart, Ralph A ...
-
Dolby, Anthony J ...
-
Stebbins, Amanda
-
Cannon, Christop ...
-
Budaj, Andrzej
-
visa fler...
-
Linhart, Ales
-
Pais, Prem
-
Diaz, Rafael
-
Steg, Philippe G ...
-
Krug-Gourley, Su ...
-
Granger, Christo ...
-
Hochman, Judith ...
-
Koenig, Wolfgang
-
Harrington, Robe ...
-
Held, Claes, 195 ...
-
Wallentin, Lars, ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
American Heart J ...
- Av lärosätet
-
Uppsala universitet